The European Commission signs a new deal with Pfizer and BioNTech to purchase 900 million doses of its vaccine with an additional option to purchase another 900 million doses for delivery from 2021 to 2023 which they intend to use as booster shots against the illness and to allow for the vaccination of children and teenagers.